Sinovac Biotech (SVA) P/E (2010 - 2026)
Sinovac Biotech (SVA) P/E from Dec 31, 2010 to Jul 21, 2026. The TTM Sinovac Biotech (SVA) P/E is -2.34. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sinovac Biotech (SVA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.34 | N/A |
| 2025 | -2.34 | -107.29% |
| 2023 | 32.07 | +56031.17% |
| 2022 | 0.06 | N/A |
| 2021 | 0.06 | -99.02% |
| 2020 | 5.82 | -72.46% |
| 2019 | 21.13 | -6.77% |
| 2018 | 22.67 | -103.03% |
| 2017 | -748.75 | +216.67% |
| 2016 | -236.44 | +3.15% |
| 2015 | -229.23 | +18.59% |
| 2014 | -193.30 | -522.88% |
| 2013 | 45.71 | -595.46% |
| 2012 | -9.23 | -34.28% |
| 2011 | -14.04 | -51.33% |
| 2010 | -28.84 | N/A |
Comparison Sinovac Biotech (SVA) P/E with competitors
Sinovac Biotech (SVA) P/E is -2.34.